News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Company News

Cardinal Health Introduces New Presource® Medication Labels
03/20/2006

McGaw PARK, Ill., March 16, 2006 – Cardinal Health (NYSE:CAH), the leading provider of products and services supporting the health care industry, announced today the introduction of Presource® Standard Medication Label Sheets, designed to help health-care providers comply with Requirement 3D of the Joint Commission on Accreditation of Healthcare Organization’s (JCAHO) 2006 National Patient Goals that took effect January 1, 2006.

 

To help meet the varying needs of its customers, Cardinal Health’s Presource® team developed a wide range of waterproof label sheets for the Operating Room, Labor and Delivery, the Catheterization and Electrophysiology Labs. The label sheets can be placed in custom procedure packs or purchased as single sterile items.  They are available with and without a location for date and initials to meet each hospital’s individual implementation plans.

 

About Cardinal Health



Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $75 billion, global company serving the health-care industry with a broad portfolio of products and services.  Through its diverse offering, Cardinal Health delivers integrated health-care solutions that help customers reduce their costs, improve efficiency and deliver better care to patients.  The company manufactures, packages and distributes pharmaceuticals and medical supplies, offers a range

 

of clinical services and develops automation products that improve the management and delivery of supplies and medication for hospitals, physician offices and pharmacies.  Ranked No. 16 on the Fortune 500, Cardinal Health employs more than 55,000 people on six continents.  More information about the company may be found at www.cardinalhealth.com.

More Company News
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

04/07/2021

By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health

04/07/2021

Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...

03/30/2021

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields